Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA)

Giulia Chiesa; Maria Grazia Zenti; Andrea Baragetti; Carlo M. Barbagallo; Claudio Borghi; Furio Colivicchi; Aldo Maggioni; Davide Noto; Matteo Pirro; Angela A. Rivellese; Tiziana Sampietro; Francesco Sbrana; Marcello Arca; Maurizio Averna; Alberico L. Catapano

doi:10.1016/j.numecd.2023.07.019

Related publications

Article2023

Lipoprotein (a), Inflammation, and Atherosclerosis

Stefania Angela Di Fusco, Aldo Maggioni, Pietro Scicchitano, Marco Zuin, Emilia D’Elia, Furio Colivicchi

Preprint2023

Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study (Preprint)

Yingxin Liu, Ruoting Wang, Shuai Li, Changfa Zhang, Professor Gregory Lip, Lehana Thabane, Guowei Li

Article2023

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

Elena Olmastroni, Marta Gazzotti, Maurizio Averna, Marcello Arca, Patrizia Tarugi, S. Calandra, S Bertolini, Alberico L. Catapano, Manuela Casula, Marcello Arca, Laura D’Erasmo, Maurizio Averna, Angelo B. Cefalù, Andrea Bartuli, Paola Sabrina Buonuomo, Andrea Benso, Guglielmo Beccuti, Giacomo Biasucci, Maria Elena Capra, Gianni Biolo, Pierandrea Vinci, Luca Bonanni, Claudio Borghi, Sergio D’Addato, Antonio Bossi,

Article2024

Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents?

Marco Giussani, Antonina Orlando, Elena Tassistro, Erminio Torresani, Giulia Lieti, Ilenia Patti, Claudia Colombrita, Ilaria Bulgarelli, Laura Antolini, Gianfranco Parati, Simonetta Genovesi

Article2025

Abstract 4348302: Olpasiran Outperforms Other Subcutaneous Lipoprotein(a)-Lowering Agents in Efficacy and Safety: A Network Meta-Analysis of Randomized Controlled Trials

Lokman Hekim Tanrıverdi, Metin Doğan, Angela Su, Ryan Shan, Maciej Banach, Adrían V. Hernández